- In December 2024, Maruti Suzuki reported total sales of 178,248 units.
- Sales increased by 30% compared to the same period last year.
- Local sales reached 140,829 units, marking a 27% increase year-over-year.
- Exports surged to 37,419 units, representing a 39% rise compared to December 2023.
- Analysts’ recommendations include 35 buy ratings, 11 hold ratings, and 3 sell ratings for Maruti Suzuki stocks.
- The comparison is based on the company’s original sales disclosures from previous years.
“`
A look at Maruti Suzuki India Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Maruti Suzuki India Limited, a leading automobile manufacturer, has received a promising overall outlook based on Smartkarma Smart Scores. With a strong focus on delivering value, Maruti Suzuki scored a respectable 3 in the Value category. This indicates that the company is deemed to offer good value to investors. Furthermore, Maruti Suzuki excels in providing dividends, achieving a top score of 5 in this area. Investors can expect consistent and significant dividend payouts from the company.
In terms of growth and resilience, Maruti Suzuki is positioned well for the long term with scores of 4 in both categories. This signifies a positive outlook for the company’s potential growth opportunities and its ability to weather challenges. However, the company scored a 2 in Momentum, suggesting that it may have some challenges in this area. Overall, Maruti Suzuki India‘s collaboration with Suzuki of Japan to produce affordable cars for the average Indian has established it as a key player in the automotive industry with a promising future ahead.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
